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High-Energy Protons: Target Fragmentation. Radiat. Res. 127, 
130-137 (1991). 
High-energy protons traversing tissue produce local sources 
of high-linear-energy-transfer (LET) ions through nuclear frag- 
mentation. We examine the contribution of these target frag- 
ments to the biological effectiveness of high-energy protons us- 
ing the cellular track model. The effects of secondary ions are 
treated in terms of the production collision density using en- 
ergy-dependent parameters from a high-energy fragmentation 
model. Calculations for mammalian cell cultures show that at 
high dose, at which intertrack effects become important, pro- 
tons deliver damage similar to that produced by y rays, and with 
fragmentation the relative biological effectiveness (RBE) of pro- 
tons increases moderately from unity. At low dose, where sub- 
lethal damage is unimportant, the contribution from target frag- 
ments dominates, causing the proton effectiveness to be very 
different from that of y rays with a strongly fluence-dependent 
RBE. At high energies, the nuclear fragmentation cross sections 
become independent of energy. This leads to a plateau in the 
proton single-particle-action cross section, below 1 keV/pm, 
since the target fragments dominate. o 1991 Academic Press, Inc. 
INTRODUCTION 
Human exposure to ionizing radiation is most often at 
low doses at which more than one particle is not likely to 
traverse individual cells. The general population is exposed 
to very low levels of the highly ionizing particles of galactic 
cosmic rays (GCR) (I). Astronauts are also exposed to very 
low fluences of GCR (2), but the major exposure comes 
from trapped particle radiation. Solar flares can contribute 
a small increment to the total exposure, the dose depending 
on the orbital inclination. The high-linear-energy-transfer 
(LET) component of the cosmic rays is of principal concern 
because of the lack of human data (3) for assessing their 
effects. Ongoing efforts are being made to study the effects 
' Present address: NASA Langley Research Center, Hampton, VA 
23665. 
of these high-LET components (4-6), although much work 
remains, especially at low dose levels. However, the major 
component of the cosmic rays is low-LET protons, repre- 
senting about 90% of the cosmic-ray flux. Nuclear fragmen- 
tation effects are also seen to be important in assessing ex- 
posures to heavy ions, with protons produced with the great- 
est frequency in such events. An understanding of the 
biological effects of high-energy protons is then required at 
the level of single-particle action for a comprehensive as- 
sessment of the risks from GCR. 
The relative biological effectiveness (RBE) of high-energy 
protons has been observed to be similar to that of X rays or 
60Co y rays in a variety of experiments with mammalian 
cell cultures and animals (see, for example, Refs. (7-lo)), 
with some variation in effectiveness observed for different 
biological end points, dose levels, dose rates, and postirradi- 
ation time (see Ref. ( 7 )  for RBE values for protons). This 
similarity between proton effectiveness and that of X or y 
irradiation is attributed to the resemblance between the 
spatial and energy distribution of secondary electrons from 
low-LET protons and the distribution of electrons from 
gamma rays. It has been noted that the contributions of 
high-LET secondary ions increase the proton RBE from 
unity in comparison to y rays in clinical therapy studies (7, 
8). In survival experiments with Chinese hamster cells irra- 
diated with 160-MeV protons at the plateau region of the 
Bragg curve and in a spread-out Bragg peak (lo), a rising 
RBE with decreasing dose was seen below doses of 2 Gy. A 
limiting maximum in the RBE was predicted (10) for 
smaller values of proton dose, based on the assumption of a 
linear-quadratic dose-response model. The RBE increases 
as the dose of the reference radiation is decreased until the 
responses to both the reference low-LET radiation and the 
high-LET radiation become linear (6, 11). This would also 
hold for the RBE of nuclear fragments with proton irradia- 
tion. We note that in experiments to date, survival data for 
proton irradiations seldom extend to doses below 1 Gy. 
Energetic protons passing through tissue produce local 
sources of high-LET fragmentation products which should 
contribute to the proton effect. Since production of 6 rays 
causes biological damage, the modification to the local dis- 
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tribution of 6 rays which scales as P2/p2,  where Z* is the 
effective charge number and P the velocity, may be signifi- 
cant for the low-energy, higher-charge secondaries in tis- 
sues. We expect the fragmentation contribution to be least 
important at high dose or fluence, where many protons will 
pass through a single cell. Here, the direct ionization from 
primary protons is adequate for producing damage without 
the help of the local secondaries. It is in the initial portion of 
biological response curves where we expect the secondary 
ions to be most important. With the action of single protons 
representing a small probability for producing the biologi- 
cal effect, the high-LET fragments will dominate if nuclear 
production cross sections are sufficiently large. 
The cellular track model of Katz et al. (12-14) describes 
both the intratrack and intertrack action of ions on biologi- 
cal systems through the ion-kill and y-kill modes of cellular 
damage. The model is parametric, relying on survival 
curves for X rays or y rays and track-segment irradiations 
with heavy ions for its parameters with the underlying for- 
malism allowing for generalizations to arbitrary ions. The 
track model has enjoyed a variety of successes in describing 
and predicting effects in a host of biological systems. In 
working with a parametric model, a mechanistic descrip- 
tion of the cellular response to radiation is avoided, and 
cell-cycle dependence and repair of sublethal damage are 
not considered. In this paper, we introduce modifications 
to the track model to account for the effects of target frag- 
mentation in determining the biological effectiveness of 
high-energy protons. Fragmentation contributions are de- 
scribed, using a recently developed nuclear fragmentation 
model (15). The fragmentation parameters are expected to 
contain some uncertainties, because measurements are 
scarce. The dependence of the proton RBE on energy is 
studied using cellular response parameters for Chinese 
hamster cells (14). An effective action cross section for the 
combined effects of protons and tissue secondaries (nuclear 
stars) is considered. Comparisons are made to the survival 
measurements of Ref. (10) in the plateau region of the 
Bragg curve using the Katz model and the high-energy 
baryon transport code, BRYNTRN (16). 
CELLULAR TRACK MODEL 
The cellular track model of Katz has been described ex- 
tensively (12-14). Here, we outline its basic concepts and 
discuss the inclusion of target fragmentation for proton 
irradiations. The track model attributes biological damage 
from energetic ions to the secondary electrons (6 rays) pro- 
duced along the ion path. Cell inactivation is separated into 
a so-called grain-count regime, where inactivation occurs 
randomly along the path of the particle, and into the so- 
called track-width regime, where many inactivations occur 
and are said to be distributed like a "hairy-rope." Four cel- 
lular parameters describe the response of the cells, two of 
which (m, the number of targets per cell, and Do, the char- 
acteristic X-ray dose) are extracted from the response of the 
cellular system to X and y irradiation. The other two (ao 
interpreted as the cross-sectional area of the cell nucleus 
within which the inactivation sites are located, and K, a mea- 
surement of the size of the inactivation site) are found prin- 
cipally from survival measurements after track-segment 
irradiations with energetic charged particles. The transition 
from the grain-count regime to the track-width regime 
takes place at a P 2 / ~ P 2  of about 4: at lower values we are in 
the grain-count regime, and at higher values the track- 
width regime. 
To accommodate for the capacity of cells to accumulate 
sublethal damage, two modes of inactivation are identified: 
"ion-kill" (corresponding to intratrack effects) and 
"gamma-kill" (corresponding to intertrack effects). When 
the passage of a single ion damages cells, the ion-kill mode 
occurs. In the grain-count regime the fraction of cells dam- 
aged in the ion-kill mode is taken as P = a/ao, where a is the 
single-particle inactivation cross section, and Pis the proba- 
bility of damage in the ion-kill mode. The track model as- 
sumes that a fraction of the ion dose, (1 - P), acts cumula- 
tively with that from other particles to inactivate cells, in 
the gamma-kill mode. The surviving fraction of a cellular 
population No, whose response parameters are m, Do, a,, 
and K after irradiation by a fluence of particles F, is written 
(12) 
where 
is the ion-lull survival probability and 
is the gamma-lull survival probability. The gamma-kill 
dose fraction is 
where D is the absorbed dose. The single-particle inactiva- 
tion cross section a is taken in the grain count regme as 
where the effective charge number is given by 
In the track-width regime, we use the approximation from 
Roth and Chang2 
R. A. Roth and Y. L. Chang, private communication, 1977. 
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where C, = 0.03935 17, C2 = -0.130822, and C3 
= 0.001 37756, which allows for a > a,, but does not repre- 
sent the "hook" structure observed (14) for very high-LET 
ions. In the track-width regime, P > 1, we take ir, = 1. 
The RBE at a specific survival level is given by 
RBE = DJD, (8) 
where 
is the X-ray dose at which this level is obtained. Of particu- 
lar interest is the low fluence limit of Eq. (8). For low doses, 
D 4 Do, where only single-track effects occur, the RBE is 
approximately (1 7) 
We next extend the track model to include the effects of 
target fragmentation in tissue. 
TARGET FRAGMENTATION 
High-energy protons passing through tissue will occa- 
sionally suffer nuclear reactions that produce low-energy, 
high-LET ions from the tissue itself. The target fragments, 
in turn, will be a source of &ray production which may 
contribute to biological damage locally in the tissue matrix. 
Using collision density formalism, the differential fluence 
(1 5, 18) describing the local source of target fragments can 
be rewritten as 
where j is the fragment label, S the stopping power or LET, 
Xj the macroscopic nuclear production cross section, and 
F, the fluence of protons with energy E,. An effective ac- 
tion cross section for the proton including the target frag- 
ments (nuclear stars) is now written as 
where a, and aj are given by the Katz formalism (Eqs. (5)- 
(7)). The gamma-kill dose for the proton-plus-target frag- 
ments is written 
The production energy spectra for the target fragments 
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FIG. 1. Integral LET spectra [F (>LET) per proton] for nuclear frag- 
ments produced by 1-GeV protons in water as a function of fragment LET 
(keV/pm). Solid line, all fragments; dotted line, secondary protons; and 
dashed line, secondary a particles. 
where 3EOJ is the average energy of the fragment. 
The fragmentation parameters used are discussed in Ref. 
(15). The cross sections for light-ion production are from 
the results of Bertini using the Monte Carlo code (1 9) and 
the Silberberg-Tsao empirical model is used for the heavier 
fragments (20). The average energy of the tissue fragments 
is related to the momentum width measured experimen- 
tally (21), which Wilson et al. (15) fitted empirically. We 
note that the largest uncertainties exist for light-ion produc- 
tion ( A  = 2 and 9) and for energies below 100 MeV. Elastic 
recoils and meson production, above several hundred 
MeV, will also contribute and should be added. The stop- 
ping power in tissue is from the work of Wilson et al. (22) 
based on the analysis of Ziegler (23). 
The solid line in Fig. 1 displays the fragment LET compo- 
nent from 1-GeV protons in tissue derived from Eq. (1 I). 
The dotted and dashed lines show the contributions from 
proton-fragment and a secondaries, respectively. 
The proton action cross section for cell survival of Chi- 
nese hamster cells is shown in Fig. 2 as a function of the 
proton energy. The cellular response parameters (1 4) are Do 
= 1.82 Gy, m = 3, a, = 4.28 X lo-' cm2, and K = 1100 as 
fitted to the data from Skarsgard et al. (24). Discussed be- 
low are comparisons to the data of Hall et al. (10) for sur- 
vival of Chinese hamster cells where the characteristic X- 
ray dose, Do, is taken as 2.9 Gy, as found from their X-ray 
data, and with the remaining parameters the same as given 
by Katz et al. (14). The dotted line in Fig. 2 shows the 
BIOLOGICAL EFFECTIVENESS OF HIGH-ENERGY PROTONS 133 
- l u ~ o ~  101 102 1 0 3  1 0 4  
Proton energy, MeV 
FIG. 2. Calculated values of the proton action cross section for sur- 
vival of Chinese hamster cells as a function of the proton energy. Dotted 
line is primary proton contribution, dashed line is the tissue fragmentation 
contribution, and solid line is the total. 
contributions from primary ionization; the dashed line 
shows contributions from secondary ions. We note that the 
oxygen and nitrogen fragments contribute partially to the 
cross section in the track-width regime. The decreasing pro- 
ton LET with increasing energy is seen to lead to complete 
domination by target fragments above about 50 MeV. The 
shape of the action cross section in Fig. 2 directly reflects 
the nuclear absorption cross section in tissue. We expect a 
further increase above several hundred MeV when meson 
production is included in the cross section. In Table I, the 
individual contributions to the action cross section are 
shown for several proton energies. Secondary protons and 
a's are dominant with a broad spectrum of fragments mak- 
ing minimal contributions. The primary proton makes up 
an insignificant fraction of the action cross section above 
100 MeV, and the relatively slow change with energy of the 
nuclear production cross sections leads to a plateau in the 
action cross section at high proton energies. 
Figure 3 shows the action cross section as a function of 
proton LET with the calculations of Fig. 2, extended down 
to 0.1 MeV, corresponding to high-LET protons. The be- 
havior of the cross section below 0.5 keV/pm shows the 
dominance of the tissue secondaries (nuclear stars). At 
about 0.2 keV/pm, the proton LET reaches a minimum 
and then increases, which is the origin of the hook in Fig. 3 
at the lowest LET values. It would be interesting to test our 
results for the proton cross section by experiment. Results 
herein assume an equilibrium in the local secondary 
fluence spectra, and are sensitive to interface effects (25) 
and the composition of the host media of the cell culture. 
In Fig. 4 we show the proton gamma-kill dose divided by 
Do as a function of proton energy. The results for the pri- 
mary ionization are shown by the dotted line and the effects 
of fragments are included in the solid line. The production 
of secondary ions is seen to have a negligible effect on inter- 
track effects, except at the highest energies where a small 
contribution is seen. 
SURVIVAL CURVES AND THE PROTON RBE 
Cell survival curves for lo-, loo-, and 1000-MeV protons 
are shown as a function of absorbed dose in Figs. 5-7. The 
solid lines include the target fragment terms and the dotted 
lines neglect their contributions. Results show the impor- 
tance of the production of secondary ions for increasing 
energy. We note, for example, that at 1000 MeV the in- 
crease in cell death due to the fragments does not lead to 
substantial changes in RBE at high doses as can be calcu- 
lated from Fig. 7. The RBE based on the initial portion of 
the survival curves for proton and 7 irradiation may be 
large. The RBE versus dose is shown in Fig. 8 with all curves 
including the effects of target fragmentation. We note that 
TABLE I 
Target Fragment Contributions to Proton Action Cross 
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FIG. 3. Calculated values of the proton action cross section for sur- FIG. 5. Calculated cell surviving fraction of Chinese hamster cells for 
viva, of Chinese hamster as a function ofthe proton LET, ~i~~~ same IO-MeV Protons. The dashed line is the primary proton and the solid line 
as in Fig. 2. includes the effects of nuclear fragments. 
fects can be attributed to contributions of the production of 
the proton fluence is found as Fp = 6.24D/LET, with Fp in secondary ions to the ion-kill mode. 
~ a r t i c l e s l ~ ~ m ~ ,  in Fins. 6 and 8. The rise in RBE at low dose 
. . 
or fluence, where single proton tracks dominate, is directly EFFECTIVENESS OF 160-MeV PLATEAU- 
attributed to ion kill from both primary protons at 10 MeV REGION PROTONS 
. . 
and nuclear fragments at the higher energies. Not shown are 
RBE calculations neglecting the target fragments that are 
nearly identical to the results for 10-MeV protons shown in 
Fig. 8, and are almost identical to unity for the 100- and 
1000-MeV protons. The relationship of RBE to dose can be 
seen from Eq. (lo), where for m = 3, using the data of 
Skarsgard et al. (24), Katz et al. (14) and Katz and Cucin- 
otta (1 7) have found an RBE dependence on D-213. This 
effect is supported experimentally as discussed below. An 
increasing RBE with decreasing dose has also been ob- 




Proton energy, MeV 
FIG. 4. Calculated values of the proton gamma-kill dose (DJD,) for 
survival of Chinese hamster cells as a function of the proton energy. The 
dotted line is the primary proton contribution and the solid line includes 
contributions from fragmentation. 
Cell survival experiments have been performed at the 
Harvard Cyclotron to determine the biological effective- 
ness of the protons. In Ref. (lo), V79 Chinese hamster cells 
cultured in vitro were irradiated in the plateau region of the 
Bragg curve and in a spread-out Brag  peak. Here we com- 
pared the survival measurements and RBE determinations 
for attached cells in the plateau region of the 160-MeV pro- 
ton Bragg curve using the track model and the high-energy 
nucleon transport code BRYNTRN (16). 
The nucleon transport code BRYNTRN solves the cou- 
pled proton-neutron transport problem for high energies in 
the straight-ahead approximation with multiple-scattering 
and straggling effects ignored. Target fragments with A > 1 
are transported using the production collision density as 
given in Eq. (1 1). The Boltzmann equations for proton and 
neutron transport are (1 6) 
and 
where 4j is the differential flux of type j particles at x with 
energy E, S,(E) is the proton stopping power; Z,(E) and 
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FIG. 6.  Calculated cell surviving fraction of Chinese hamster cells for 
100-MeV protons. The dashed line is the primary proton and the solid line 
includes the effects of nuclear fragments. 
Z,(E) are proton and neutron total cross sections, respec- 
tively; andL,(E, E') represents the differential cross sections 
for elastic and inelastic processes. As described in Refs. (16, 
17), the Boltzmann equations (1 3) and (1 4) are solved using 
a characteristic transformation to reduce the problem to a 
set of coupled integral equations with boundary conditions 
at x = 0, which are then solved numerically. More details 
on the method of solution and the data base for nuclear 
scattering are found in Ref. (16). The Brag  curve obtained 
from BRYNTRN for 160-MeV protons in water is shown 
in Fig. 9 compared to the measurements of Verhey et al. 
l o  1000 MeV protons 
Gel! 
surviv~ng 1 0-2 
fraction 
10-4  5 I I , \ I 10 15 20 
Dose (Gy) 
FIG. 7.  Calculated cell surviving fraction of Chinese hamster cells for 
1000-MeV protons. The dashed line is the primary proton and the solid 
line includes the effects of nuclear fragments. 
RBE 10' 
10 O 
10-2 10-1 100 10 
Dose, Gy 
FIG. 8. Calculated proton RBEs for survival of Chinese hamster cells 
as a function of the absorbed dose. In increasing order: lo-, loo-, 1000- 
MeV protons. 
(28) (solid line). In Fig. 9, the squares represent the primary 
dose and the circles the total dose with secondary produc- 
tion included. Calculations are normalized to the peak of 
the experimental Bragg curve. Straggling and multiple-scat- 
tering effects, which are not included here, both contribute 
significantly at the peak of the Brag  curve. We consider the 
plateau region where the assumptions for high-energy pro- 
tons are approximately true. 
At 160 MeV, nuclear recoils from elastic scattering pro- 
vide a sizable correction to the production of secondary 
ions represented by target fragmentation. Elastic scattering 
is represented by the Born term to the optical model renor- 
malized to the total scattering cross section in the 
BRYNTRN code. This representation of elastic scattering 
is fairly accurate for integral quantities above 100 MeV, but 
breaks down at lower energies because of multiple scatter- 
ing, nuclear-medium corrections, and coulomb effects. The 
correction of the action cross section for protons, taking 
into consideration the elastic scattering, is shown in Table 
I1 for several energies and is included in the following com- 
parisons. 





Depth in water, cm 
FIG. 9. Depth-dose curve for unmodulated 160-MeV proton beam in 
water. The measurements of Verhey et al. (28) (solid line) are compared to 
calculations with nuclear secondaries (0) and without secondaries (0). 
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TABLE I1 
Secondary Ion Production Contribution to Proton Action 
Cross Section for V79 Chinese Hamster Cells 
cr (lo-'' cm2) 
E (MeV) Elastic recoils Fragmentation 
cells irradiated in suspension in the plateau region of a 160- 
MeV proton beam are shown in Fig. 10. The dashed line is 
the fit to the y-ray survival curve, the dotted line (barely 
distinguishable from the response for y rays) is the contri- 
bution from primaries only, and the solid line includes the 
calculated effects of nuclear reactions. The characteristic 
y-ray dose, Do, is taken as 2.9 Gy to reproduce the experi- 
mental curve for y rays with the other response parameters 
given above. The survival curves for Chinese hamster cells 
irradiated with 60Co 7 rays and plateau-region 160-MeV 
protons are similar, indicating that, when the effects of the 
nuclear force are disregarded, the behavior of high-energy 
protons is like that of y rays. Agreement with the data is 
fair, indicating that the modeling of nuclear fragmentation 
made here is somewhat lacking. In Fig. 1 1, we compare our 
results for the proton RBE (solid line) against the values 
obtained using the analysis methods of Kellerer and Brenot 
(vertical bars) (29) in Ref. (10). The "bare" proton RBE has 
a value of 1 (not shown), except at the lowest doses where a 
small contribution from ion kill gives a slight increase. The 





2.0 4.0 6.0 8.0 10.0 12.0 
Dose (Gy) 
FIG. 10. Survival data for Chinese hamster cells irradiated by "Co y 
rays (0) and plateau-region 160-MeV protons (A) from Hall et a/. (10) are 
compared to calculations. The dashed line is the fit to the experimental 
y-ray survival curve, the dotted line is the result for primary protons only, 
and the solid line includes the effects of nuclear reactions. 
Proton 
RBE 
FIG. 1 1 .  Proton RBE as a function of proton dose for Chinese ham- 
ster cell survival in plateau region of the 160-MeV proton Bragg curve. 
Experimental determination from Hall et a/. (10). The vertical bars denote 
RBE values that are excluded at 95% confidence level, while the detached 
arrows indicate values that are unlikely at a lower level of confidence. The 
most likely RBE values are in the space between the vertical bars. The solid 
line is from the calculations where the effects of nuclear reactions are 
included. 
1\ 
good agreement with the values obtained experimentally, 
with the increasing RBE at low doses shifted to lower values 
than those obtained by experiment. A second method of 
analysis, which assumes that the dose-effect curve is con- 
vex but is otherwise independent of shape, was used to de- 
rive RBE values (10); the values are shown in Fig. 12 in 
comparison to the present predictions. The RBE rise at low 
dose as D-213 predicted from Eq. (10) is clearly seen in the 
calculations (solid line) and the experimental analyses 
(dashed line). Also shown in Fig. 12 by the dotted line are 









ster cell survival in plateau region of the 160-MeV proton Brag  curve. The 
dashed line is from experimental analysis in Ref. (10) as discussed in text. 
The solid line is calculations which include nuclear reaction effects, and 
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CONCLUSIONS 
The biological effectiveness of high-energy protons, when 
cellular damage proceeds through a multitarget response 
(m  > l), has been identified to be related intimately to the 
production of nuclear fragments in tissue along the track of 
the protons. Single tracks of high-energy protons produce 
an insignificant contribution to the action cross section (see 
Fig. 2); it is only through secondary nuclear reactions that 
damage occurs. The increase in RBE at low doses found in 
experiments with fast heavy ions is also found for protons 
because of the consequences of nuclear scattering. A dose- 
or fluence-dependent proton RBE has important conse- 
quences for radiation exposures in space from high-energy 
protons. The magnitude of the RBE is related to the curvi- 
linear response curve of the reference radiation. The curvi- 
linearity, in contrast to the linear response for high-LET 
radiation, reflects the repair of low-LET radiation-induced 
damage. Our calculations suggest that an understanding of 
the effects of nuclear interactions in tissue is essential for 
risk assessment for high-energy protons, especially at low 
levels of exposure. 
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